{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:54:15Z","timestamp":1779292455743,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-021-00578-1","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T20:47:33Z","timestamp":1637786853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Marie-France","family":"Gagnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn E.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Hoppman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-3376","authenticated-orcid":false,"given":"Ellen D.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5229-4897","authenticated-orcid":false,"given":"Linda B.","family":"Baughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-8000","authenticated-orcid":false,"given":"Jess F.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"578_CR1","unstructured":"Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri SA, Stein, H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edn. International Agency for Research on Cancer: Lyon, France, 2017."},{"key":"578_CR2","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2014-05-578963","volume":"124","author":"AM Petrich","year":"2014","unstructured":"Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, et al. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014;124:2354\u201361.","journal-title":"Blood"},{"key":"578_CR3","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1200\/JCO.19.00743","volume":"37","author":"A Rosenwald","year":"2019","unstructured":"Rosenwald A, Bens S, Advani R, Barrans S, Copie-Bergman C, Elsensohn MH, et al. Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol. 2019;37:3359\u201368.","journal-title":"J Clin Oncol"},{"key":"578_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12308-020-00404-w","volume":"13","author":"DP Larson","year":"2020","unstructured":"Larson DP, Peterson JF, Nowakowski GS, McPhail ED. A practical approach to FISH testing for MYC rearrangements and brief review of MYC in aggressive B-cell lymphomas. J Hematopathology. 2020;13:127\u201335.","journal-title":"J Hematopathology"},{"key":"578_CR5","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","volume":"126","author":"C Copie-Bergman","year":"2015","unstructured":"Copie-Bergman C, Cuilliere-Dartigues P, Baia M, Briere J, Delarus R, Canioni D, et al. MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study. Blood. 2015;126:2466\u201374.","journal-title":"Blood"},{"key":"578_CR6","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3324\/haematol.2018.190157","volume":"103","author":"ED McPhail","year":"2018","unstructured":"McPhail ED, Maurer MJ, Macon WR, Feldman AL, Kurtin PJ, Ketterling RP, et al. Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements is not associated with MYC\/IG gene rearrangements. Haematologica 2018;103:1899\u2013907.","journal-title":"Haematologica"},{"key":"578_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.leu.2404529","volume":"21","author":"P Bertrand","year":"2007","unstructured":"Bertrand P, Bastard C, Maingonnat C, Jardin F, Maisonneuve C, Courel MN, et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia. 2007;21:515\u201323.","journal-title":"Leukemia"},{"key":"578_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/gcc.22391","volume":"55","author":"C Otto","year":"2016","unstructured":"Otto C, Scholtysik R, Schmitz R, Kreuz M, Becher C, Hummel M, et al. Novel IGH and MYC translocation partners in diffuse large B-cell lymphomas. Genes Chromosomes Cancer. 2016;55:932\u201343.","journal-title":"Genes Chromosomes Cancer"},{"key":"578_CR9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood.2019002600","volume":"134","author":"LK Hilton","year":"2019","unstructured":"Hilton LK, Tang J, Ben-Neriah S, Alcaide M, Jiang A, Grande BM, et al. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. 2019;134:1528\u201332.","journal-title":"Blood"},{"key":"578_CR10","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","volume":"104","author":"RL King","year":"2019","unstructured":"King RL, McPhail ED, Meyer RG, Vasmatzis G, Pearce K, Smadbeck JB, et al. False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms. Haematologica. 2019;104:e248\u2013e251.","journal-title":"Haematologica"},{"key":"578_CR11","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/sj.leu.2404340","volume":"20","author":"RR Einerson","year":"2006","unstructured":"Einerson RR, Law ME, Blair HE, Kurtin PJ, McClure RF, Ketterling RP, et al. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2. Leukemia 2006;20:1790\u20139.","journal-title":"Leukemia"},{"key":"578_CR12","unstructured":"Sharma, N, Smadbeck, JB, Abdallah, N, Zepeda-Mendoza, C, Binder, M, Pearce, KE, et al. The prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma. Clin Cancer Res. In press."},{"key":"578_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/his.12178","volume":"63","author":"AM Munoz-Marmol","year":"2013","unstructured":"Munoz-Marmol AM, Sanz C, Tapia G, Marginet R, Ariza A, Mate JL. MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection. Histopathology 2013;63:418\u201324.","journal-title":"Histopathology"},{"key":"578_CR14","unstructured":"Bendig, S, Walter, W, Meggendorfer, M, Bar, C, Fuhrmann, I, Kern, W, et al. Whole genome sequencing demonstrates substantial pathophysiological differences of MYC rearrangements in patients with plasma cell myeloma and B-cell lymphoma. Leuk Lymphoma. In press."},{"key":"578_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cancergencyto.2009.12.010","volume":"198","author":"PC May","year":"2010","unstructured":"May PC, Foot N, Dunn R, Geoghegan H, Neat MJ. Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin\u2019s lymphoma by fluorescence in situ hybridization: implications for cytogenetic testing. Cancer Genet Cytogenet. 2010;198:71\u201375.","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00578-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00578-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00578-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:25:27Z","timestamp":1669919127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00578-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1038\/s41408-021-00578-1","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}